Kenneth Frazier

Kenneth C. Frazier, Merck Executive Chairman and Former CEO, Joins General Catalyst as Chairman of Its Health Assurance Initiatives

Retrieved on: 
Wednesday, July 21, 2021
Finance, Investment, Money, Entrepreneurship, Kenneth Frazier, General Catalyst, Venture capital, Kenneth Chenault, Frazier, Catalyst

In his new role at GC, Frazier will help guide the strategy of the firm’s healthcare initiatives in an effort to shift the paradigm from a “sick care” system to a resilient, proactive Health Assurance system -- designed to help people stay well, bend the cost curve through innovation, and make quality care more affordable and more accessible to all.

Key Points: 
  • NEW YORK, July 21, 2021 (GLOBE NEWSWIRE) -- The venture capital firm General Catalyst announced today that Kenneth C. Frazier, Merck Executive Chairman and former CEO, will be joining the firm in the newly created role of Chairman, Health Assurance Initiatives.
  • Under his leadership, Merck researchers made historic breakthroughs in immuno-oncology and other fields of medicine that have transformed clinical practice and greatlyimproved patient outcomes.
  • The connection between General Catalyst and Ken Frazier is his long-standing friendship with GC's chairman and managing director, Ken Chenault, with whom Frazier attended law school.
  • General Catalyst is a venture capital firm that invests in powerful, positive change that endures for our entrepreneurs, our investors, our people, and society.

Merck Appoints Caroline Litchfield Chief Financial Officer

Retrieved on: 
Wednesday, March 24, 2021
Biotechnology, Human resources, Finance, General Health, Health, Infectious diseases, Professional services, Other Health, Businesspeople, Kenneth Frazier, Merck, Chief financial officer, Corporate governance, Business, Merck & Co., Merck Group

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Caroline Litchfield has been appointed executive vice president and chief financial officer (CFO), effective April 1, 2021.

Key Points: 
  • Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Caroline Litchfield has been appointed executive vice president and chief financial officer (CFO), effective April 1, 2021.
  • Litchfield succeeds Robert M. Davis; as previously announced ( link ), Davis, Mercks current CFO, will become president of Merck, effective April 1, 2021, and will become chief executive officer on July 1, 2021.
  • Ensuring our company's sustainable financial strength is essential to enable Merck to deliver on our mission to save and improve lives and to create long-term value for all our stakeholders, said Kenneth C. Frazier, chairman and chief executive officer, Merck.
  • From 2014 to 2018, Litchfield led finance for Human Health, the companys largest business, overseeing financial operations and reporting in approximately 100 markets.

Merck to Present at the 39th Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Monday, January 4, 2021
Biotechnology, Pharmaceutical, Health, Clinical trials, Bayer, Kenilworth, New Jersey, Merck & Co., Schering-Plough, Merck, Companies, Kenneth Frazier, Pharmaceutical industry, MRK, Pharmaceutical companies

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, chairman and chief executive officer, Robert Davis, chief financial officer, and Dr. Dean Li, president, Merck Research Laboratories, are scheduled to participate in the 39th Annual J.P. Morgan Healthcare Conference on Jan. 11, 2021 at 4:30 p.m. EST.

Key Points: 
  • Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, chairman and chief executive officer, Robert Davis, chief financial officer, and Dr. Dean Li, president, Merck Research Laboratories, are scheduled to participate in the 39th Annual J.P. Morgan Healthcare Conference on Jan. 11, 2021 at 4:30 p.m. EST.
  • We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.
  • Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA
    This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the company) includes forward-looking statements within the meaning of the safe harbor provisions of the U.S.
  • These statements are based upon the current beliefs and expectations of the companys management and are subject to significant risks and uncertainties.

Merck to Present at the Morgan Stanley 18th Annual Virtual Global Healthcare Conference

Retrieved on: 
Thursday, September 10, 2020
Oncology, Health, Medical devices, Infectious diseases, Other Health, Pharmaceutical, Biotechnology, Pharmaceutical industry, Bayer, Kenilworth, New Jersey, Merck & Co., Schering-Plough, Merck, Forward-looking statement, Roger M. Perlmutter, MRK, Kenneth Frazier, Companies, Economy of the United States

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, chairman and chief executive officer, and Dr. Roger M. Perlmutter, president, Merck Research Laboratories, are scheduled to participate in a virtual fireside chat at the Morgan Stanley 18th Annual Conference on Sept. 15, 2020, at 9:30 a.m. EDT.

Key Points: 
  • Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, chairman and chief executive officer, and Dr. Roger M. Perlmutter, president, Merck Research Laboratories, are scheduled to participate in a virtual fireside chat at the Morgan Stanley 18th Annual Conference on Sept. 15, 2020, at 9:30 a.m. EDT.
  • We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.
  • These statements are based upon the current beliefs and expectations of the companys management and are subject to significant risks and uncertainties.
  • If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.